Michelle J. Bauer

Association Between Minimum Inhibitory Concentration, Beta-lactamase Genes and Mortality for Patients Treated With Piperacillin/Tazobactam or Meropenem From the MERINO Study

Andrew Henderson, David L. Paterson, Mark D. Chatfield et al. · Clinical Infectious Diseases · 2020 · 158 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase–Producing <i>Enterobacter</i> spp, <i>Citrobacter freundii</i>, <i>Morganella morganii</i>, <i>Providencia</i> spp, or <i>Serratia marcescens</i>: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)

Adam G. Stewart, David L. Paterson, Barnaby Edward Young et al. · Open Forum Infectious Diseases · 2021 · 92 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Outbreak of Serratia marcescens in a neonatal intensive care unit: contaminated unmedicated liquid soap and risk factors

Sylvie Buffet‐Bataillon, V. Rabier, P. Bétrémieux et al. · Journal of Hospital Infection · 2009 · 78 citations

Medicine, Microbiology, Pediatrics +17

Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis

David M. P. De Oliveira, Lisa Bohlmann, Trent Conroy et al. · Science Translational Medicine · 2020 · 55 citations · Full text

Life Sciences, Infectious Diseases, Pharmacology +13

Rapid nanopore sequencing and predictive susceptibility testing of positive blood cultures from intensive care patients with sepsis

Patrick N. A. Harris, Michelle J. Bauer, Lukas Lüftinger et al. · Microbiology Spectrum · 2024 · 39 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17